Atlas Trials

First-in-Human Study of Orally Administered GS-441524 for COVID-19

Clinical trial NCT04859244 · COMPLETED

Trial details

NCT number
NCT04859244
Sponsor
Copycat Sciences LLC
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
COVID-19
Start date
2021-01-01
Primary completion
2021-05-01
Enrollment
1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.